Wolff Wiese Magana’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.8K Hold
70
0.01% 424
2026
Q1
$13.7K Hold
70
0.01% 406
2025
Q4
$12.1K Hold
70
0.01% 407
2025
Q3
$13.3K Hold
70
0.01% 395
2025
Q2
$12.6K Hold
70
0.01% 365
2025
Q1
$11.8K Hold
70
0.01% 375
2024
Q4
$10.6K Hold
70
0.01% 417
2024
Q3
$10.9K Hold
70
0.01% 430
2024
Q2
$9.58K Hold
70
0.01% 329
2024
Q1
$9.32K Hold
70
0.01% 305
2023
Q4
$9.65K Sell
70
-150
-68% -$19.7K 0.01% 288
2023
Q3
$26.8K Hold
220
0.02% 244
2023
Q2
$30.9K Hold
220
0.02% 240
2023
Q1
$31.1K Hold
220
0.03% 231
2022
Q4
$34.4K Sell
220
-123
-36% -$17.7K 0.03% 214
2022
Q3
$42K Sell
343
-4
-1% -$527 0.03% 262
2022
Q2
$46K Sell
347
-10
-3% -$1.36K 0.03% 267
2022
Q1
$49K Buy
357
+70
+24% +$9.76K 0.03% 274
2021
Q4
$50K Buy
287
+110
+62% +$16.7K 0.03% 275
2021
Q3
$25K Sell
177
-19
-10% -$2.78K 0.02% 382
2021
Q2
$26K Buy
196
+68
+53% +$8.9K 0.02% 363
2021
Q1
$16K Sell
128
-4
-3% -$493 0.01% 416
2020
Q4
$16K Buy
+132
New +$16.1K 0.01% 390

Other funds holding DGX

Wolff Wiese Magana's DGX Position: Q2 2026 in Review

Wolff Wiese Magana held its Quest Diagnostics (DGX) position steady in Q2 2026 at 70 shares worth $14.8K. The position accounts for 0.01% of the portfolio, ranked #424.

Wolff Wiese Magana first reported a position in DGX in Q4 2020 and has held it in 23 quarters since. The position peaked at $50K in Q4 2021. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Wolff Wiese Magana held 70 shares of Quest Diagnostics worth $14.8K as of Q2 2026.
  • Wolff Wiese Magana left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #424 holding.
  • Wolff Wiese Magana first reported a position in Quest Diagnostics in Q4 2020 and has held it in 23 quarters since.
  • Wolff Wiese Magana's Quest Diagnostics position peaked at $50K in Q4 2021.
  • 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.